Knowledge, Practices, and Perceived Barriers in Cancer Pain Management at Oncology Units: A Cross-Sectional Survey of Medical Staff in China
Zaoqin Yu,Wei Li,Xiaofang Shangguan,Yuanxuan Cai,Qianyan Gao,Ximin Wang,Yuan Chen,Dong Liu,Chengliang Zhang
DOI: https://doi.org/10.2147/JPR.S339377
IF: 2.8319
2022-01-22
Journal of Pain Research
Abstract:Zaoqin Yu, 1, &ast Wei Li, 1, &ast Xiaofang Shangguan, 2 Yuanxuan Cai, 2 Qianyan Gao, 1 Ximin Wang, 1 Yuan Chen, 3 Dong Liu, 1 Chengliang Zhang 1 1 Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China; 2 School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China; 3 Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China &astThese authors contributed equally to this work Correspondence: Dong Liu; Chengliang Zhang Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, People's Republic of China Tel/Fax +86-27-83663643 ; +86-27-83663519 Email ; Background: Despite the great signs of progress in cancer pain management in China, the associated pain remains under-treated. Poor knowledge among the medical staff is an important factor contributing to the under-treatment of cancer pain. This study aimed to evaluate the knowledge, practices, and perceived barriers in cancer pain management among the medical staff at oncology units in China. Patients and Methods: A cross-sectional survey was conducted with the medical staff (including physicians, nurses, and pharmacists) at oncology units in tertiary hospitals of China between December 2020 and January 2021. The questionnaire assessed the knowledge, practices, and perceived barriers in cancer pain management. Results: A total of 1262 medical staff responded to the questionnaire; the response rate was 94.2%. Most participants had good knowledge of the three-step analgesic ladder of the World Health Organization (WHO) and the National Comprehensive Cancer Network (NCCN) guidelines for Adult Cancer Pain . Knowledge deficit was prominent in questions on opioid dose titration and rotation and adverse effects of opioids; the correct response rate was less than 40%. Training, work experience in oncology, and education level were significantly related to knowledge of cancer pain management (all P < 0.001). In clinical practice for cancer pain management, approximately 57.2% of medical staff were unfamiliar with opioid dose titration and rotation; only 14.4% treated cancer pain through multidisciplinary collaboration. Poor medication compliance, difficult individualized analgesia protocols, and insufficient multidisciplinary participation were the most frequently perceived barriers by the medical staff for pain management. Conclusion: These findings suggested a further need for integrating recent guidelines to strengthen continued training (especially among juniors and those with low education levels) and patient education to improve the knowledge and clinical practices of cancer pain management among the medical staff in China. Multi-disciplinary management is required for the effective treatment of cancer pain. Keywords: cancer pain, medical staff, knowledge, practices, barriers, multi-disciplinary management Globally, cancer is one of the major causes of death. 1 Pain is one of the most common and feared symptoms among cancer patients, with a prevalence of 25% at the first diagnosis and 66.4% among patients with advanced cancer; approximately one-third of patients experience moderate-to-severe pain. 2,3 In addition to the physical harm, cancer pain causes psychosocial, behavioral, emotional, and spiritual problems, thus resulting in a significant impact on the quality of life of the patients. 4–6 Therefore, cancer pain continues to be a worldwide issue. In 1986, WHO developed a three-step analgesic ladder for pain management, which recommends non-opioid analgesics for mild pain, and opioids as the first line of treatment for moderate-to-severe cancer pain. 7 According to the WHO guidelines, several other guidelines for the management of cancer pain have been established to aid in clinical decision-making, including those by NCCN and the American Society of Clinical Oncology (ASCO). 8–11 This suggests that the attention to cancer pain treatment has greatly increased, and many efforts have been made to improve the treatment of cancer pain. Following these evidence-based guidelines, it is estimated that more than 70% of cancer patients can achieve adequate pain relief. 7–11 Despite the significant progress in cancer pain treatment, evidence shows that many patients with cancer pain still exper -Abstract Truncated-
clinical neurology